Lincoln Pharmaceuticals Ltd

Stage 3 · Topping · week 13

As of 16 Oct 2026, Lincoln Pharmaceuticals is in Stage 3 — topping, where an uptrend loses steam, in week 13 (since 21 Jul 2026). It closed at ₹546, 28.0% below its 52-week high and below its 200-day average, which is rising. In Health Care, 40.6% of stocks are in Stage 2.

Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India. More about the company

₹545.6
-1.69% today
₹1,093 Cr · Small cap
Market Neutral — FadingHealth Care 40.6% in Stage 2-7.4 pts / 20dPharmaceuticals 50.4%-2.5 pts

Pro read

Pro

Our read

Topping — the uptrend is tiring

Setup score

—

Momentum

Steady

Edge

—

Is LINCOLN early, or has it already run? Pro answers that for every NSE stock, after every close.

₹2,999 · 12 months₹1,999 · 6 months
Loading price chart…
vs 52W High
-28.0%
₹444.2 lo₹758.2 hi
28.0% below 52W high — weakening from peak
Stock is rolling over from its 52W high. Stage 3 distribution — new longs are high risk here.
Stage Maturity
Week 13
1w13w26w
Week 13 — distribution, avoid new longs
How long this stock has been in Stage 3 distribution. Longer tops often precede deeper Stage 4 declines.
vs 200 DMA
-7.7%
200 DMA: ₹591.4 · rising
Stock is losing its 200 DMA. Once lost, it confirms Stage 4 risk. This is a major red flag for existing holders.
Rel Volume
0.88x
vs 50-day avg
Volume spikes on down days during Stage 3 signal distribution — institutions are exiting. A clear warning to avoid new longs.
Trend Health
↓
MA20 rolling over · -5.3% vs MA50 -1.2%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
-7.6%
3M
-8.6%
6M
-7.6%
YTD
+12.0%
1Y
+4.4%
Sector
Health Care
↓ Peaking
Stage 2%
40.6%
20d Δ
-7.4pp
1M return
-3.8%
3M return
-1.0%
Sector Stage-2 % · last 20 days
Sector has 67 Stage 2 leaders. See Health Care Stage 2 →
Industry
Pharmaceuticals
↓ Peaking
Stage 2%
50.4%
20d Δ
-2.5pp
1M return
-2.3%
3M return
-0.6%
Industry Stage-2 % · last 20 days
Industry has 57 Stage 2 leaders. See Pharmaceuticals Stage 2 →
Stage Cycle Timeline2023-07-20 → 2026-10-16
S2 36w
S2 15w
S4 31w
S2 19w
2023-07-202026-10-16
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 36w → S3 10w → S4 4w → S1 3w → S2 15w → S3 5w → S2 10w → S3 3w → S4 11w → S1 7w → S4 31w → S1 3w → S2 19w → S3 13w current
Total tracked: 169 weeks across 14 stage runs.
Scan Membership
Prop Scan
Latest: 2026-06-16
Pullback Hunter
Latest: 2026-06-16
Breakout Watch
Latest: 2026-03-13
38 appearances in last 60 days. First seen: 2024-07-23.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding — staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-16S3
Wk 13 · Vol 0.88x
2026-10-15S3
Wk 13 · Vol 0.92x
2026-10-14S3
Wk 12 · Vol 0.36x
2026-10-13S3
Wk 12 · Vol 0.31x
2026-10-12S3
Wk 12 · Vol 0.69x
2026-10-09S3
Wk 12 · Vol 0.36x
2026-10-08S3
Wk 12 · Vol 0.54x
2026-10-07S3
Wk 11 · Vol 0.51x
2026-10-06S3
Wk 11 · Vol 0.30x
2026-10-05S3
Wk 11 · Vol 0.55x
2026-10-01S3
Wk 11 · Vol 1.19x
2026-09-30S3
Wk 11 · Vol 0.37x
Sector Peers — Stage 2All →
BAFNAPH
wk 19 · 0.0% from hi
8.6
KILITCH
wk 3 · -11.6% from hi
8.4
LAURUSLABS
wk 26 · -0.4% from hi
7.8
KOPRAN
wk 20 · -6.8% from hi
7.4
ZIMLAB
wk 23 · -5.2% from hi
6.9
Moving averages & range
50 DMA
₹598.2
200 DMA
₹591.4
52W High
₹758.2
52W Low
₹444.2
5D Low
₹542.9
Resistance levels (recent highs)
20d High
₹604.9
60d High
₹639.8
120d High
₹758.2
250d High
₹758.2
Next resistance
+10.9%
to 20d High
Ask the Market AI about LINCOLNAsk →
P/E (TTM)
17.3
Forward —
Earnings Growth (YoY)
+37.7%
Revenue +13.5%
Dividend Yield
0.24%
P/B 2.1
About this companyHealth Care· Pharmaceuticals

Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India. The company offers products in the areas of anticold, antibiotic, otolaryngology, pain management, gastro, anti-malarial, anti-fungal, corticosteroids and cosmo-derma, anti-diabetic, anti-hypertensive, gynecology, cardio and CNS, respiratory system, and dyslipidemic; and branded generics. It also exports its products to approximately 60 countries, including Europe, Canada, Latin and North America, Africa, the Asia Pacific, and South East Asia. Lincoln Pharmaceuticals Limited was incorporated in 1979 and is based in Ahmedabad, India.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-16. Past data patterns are not indicative of future results. This page is a data analytics tool only.